Organization
Updated NCCN Guidelines Adjust Ratings for Prostate Cancer Genetic Tests
The newest version ups its endorsement of somatic genomic testing to "recommended" for advanced cancers and shifts its recommendations on early-stage risk assays.
In Brief This Week: Myriad Genetics, Thermo Fisher Scientific, DeepUll, Roche, Immunovia, More
News items for the weeks of Nov. 25 and Dec. 2, 2024.
Cepheid Tuberculosis Assay Receives WHO Prequalification
The WHO noted that Cepheid's test is the first test for tuberculosis and antibiotic susceptibility testing that meets the prequalification standards.
VA Offering No-Cost PGx Testing Through End of 2025
The program will be rolled out within Veterans Integrated Service Network 4 facilities, which served more than 300,000 patients last year.
The McGill University team is advancing a test, dubbed DOvEEgene, which sequences DNA from a uterine brush sample to detect cancer-associated mutations.
Dec 2, 2024
Nov 27, 2024
Nov 27, 2024
Nov 22, 2024
Nov 20, 2024